2021 NLCRT Annual Meeting

2021 NLCRT Annual Meeting

2021 NLCRT Annual Meeting

December 6-7, 2021

Disparities to Equity: Moving the  Needle on Lung Cancer

Each year, the NLCRT membership, a nationwide coalition of over 160 professional and national societies, cancer centers, government agencies, research groups, advocacy and policy organizations, and corporate associates convenes to work together on our shared goal to create lung cancer survivors.

The 2021 virtual conference featured the work of those who are shaping a more equitable direction to lung cancer care and control in areas such as risk reduction, early detection, tobacco prevention and treatment, diagnosis and therapy, survivorship, and policy. The overarching goal of the conference was to address the determinants of minority health and cancer-related health disparities to advance health equity across the lung cancer continuum.

The conference highlighted keynote presentations and conversations led by Monica Webb Hooper, PhD, Deputy Director of the National Institute on Minority Health and Health Disparities, and Robert A. Winn, MD, Director of the Massey Cancer Center at Virginia Commonwealth University. In addition, the NLCRT showcased its strategic priority committees’ work and its initiatives that focused on eliminating lung cancer stigma, promoting lung cancer screening implementation, uptake, and adherence, and optimizing lung cancer biomarkers in practice.

Through the NLCRT, we are working to ensure that no one is disadvantaged in their fight against lung cancer because of their socioeconomic status, their race or ethnicity, their sexual orientation, their gender identity, their disability status, their insurance status, or where they live.

We thank all of NLCRT organizational members and non-members along with advocates, survivors, and caregivers for attending the 5th Annual Meeting.

Not currently a member? Learn more about NLCRT membership.

See the 2021 Meeting Agenda

See the 2021 Meeting Program

See the 2021 Meeting Executive Summary

Day 1 Keynote Speaker

Monica Webb Hooper, PhD

Deputy Director of the National Institute on Minority Health and Health Disparities, National Institutes of Health

Monica Webb Hooper, PhD, is a leader in minority health and cancer-related health disparities research. Her work spans multiple disparity populations, including African Americans, Hispanics/Latinos, persons of lower socioeconomic privilege, and people living with HIV/AIDS.

Day 2 Keynote Speaker

Robert A. Winn, MD

Director and Lipman Chair in Oncology
VCU Massey Cancer Center

Robert A. Winn, MD, is the director of the VCU Massey Cancer Center, a cancer center designated by the National Cancer Institute that provides advanced cancer care, conducts groundbreaking research to discover new therapies for cancer, offers high-quality education and training, and engages with the community to make advancements in cancer treatment and prevention equally available to all.


See the presentation slides (if they are available) by clicking on the links in the table.[vc_tta_tabs]Session Descriptions & Recordings10:00am – 10:15am ET

Session Recording


Welcome and Opening Remarks
Ella Kazerooni, MD, MS, FACR, FSABI, NLCRT Chair, University of Michigan

Patient Advocate Story

Ida Pittman, Helena Price, and Cherie P. Erkmen, MD, Temple University Hospital10:15am – 11:45pm ET


Deconstructing Disparities to Prevent and Cure Lung Cancer

Keynote Speaker

Monica Webb Hooper, PhD, National Institute on Minority Health and Health Disparities


Jill Feldman, EGFR Resisters
Louis A. Penner, PhD, FSESP, Karmanos Cancer Institute
David T. Cooke, MD, FACS, University of California, Davis Medical Center
John P. Williams, MD, FACS, President’s Cancer Panel


M. Patricia Rivera, MD, ATSF, FCCP, University North Carolina at Chapel Hill2:15pmBreak12:20pm – 1:40pm ET

Session Recording


Examining Disparities and Equity in Lung Cancer Across the Care Continuum

Part 1: Promoting Equity Through Reaching Diverse and Vulnerable Populations



Leah M. Backhus, MD, MPH, FACS, Standford University


Lung Cancer is Just Different: Understanding the Population is the First Step in Reducing Disparities. Gerard A. Silvestri, MD, MS, FCCP, Medical University of South Carolina

Understanding the Hispanic Health Paradox in the Context of Lung Cancer. Heidi A. Hamann, PhD, University of Arizona

Geographic Access to Lung Cancer Screening Among Eligible Adults Living in Rural and Urban Environments in the US. Liora Sahar, PhD, GISP, Grace GIS

Feasibility and Acceptability of a Collaborative Lung Cancer Screening Educational Intervention Tailored for Individuals with Serious Mental Illness. Kelly E. Irwin, MD, MPH, Massachusetts General Hospital

Community Engagement Towards Increasing Lung Cancer Screening. Alexandra Potter, American Lung Cancer Screening Initiative

Studying Trial Determinants of Success (STRIDES): Understanding Barriers and Facilitators to Clinical Trial Accrual Among Patients with Lung Cancer in the Deep South. Andrew Ciupek, PhD, GO2 Foundation for Lung Cancer

ACR Lung Cancer Screening Improvement CollaborativeNeville Irani, MD, University of Kansas Medical Center

Kentucky Health Collaborative: Lung Cancer Screening, Detection, and Treatment InitiativeTimothy W. Mullett, MD, MBA, FACS, University of Kentucky

ScreenNJ: A Statewide Prevention and Screening Program. Anita Y. Kinney, PhD, RN, FAAN, FABMR, Rutgers Cancer Institute of New Jersey1:45pm – 3:05pm ET

Session Recording

Part 2: Innovation and Advancement in the Lung Cancer Field



Juan P. Wisnivesky, MD, DrPHMount Sinai Health System


Advancing Payment Models Towards Lung Cancer Screening UptakeA. Mark Fendrick, MD, University of Michigan

Harnessing the EMR: Lung Cancer Screening Shared Decision-Making Tool Integration into EPIC. Tanner Caverly, MD, MPH, University of Michigan; Kensaku Kawamoto, MD, PhD, MHS, FACMI, FAMIA, University of Utah

Department of Veterans Affairs Lung Precision Oncology Program. Christopher G. Slatore, MD, MS, Oregon Health & Science University

Molecular Screening and Early Diagnosis of Cancer. Sana Raoof, MD, PhD, Memorial Sloan Kettering Cancer Center

Barriers to Equitable Biomarker Testing in Underserved Patients with NSCLC. Leigh M. Boehmer, PharmD, BCOP, Association of Community Cancer Centers

Small Cell Lung Cancer Initiative. Jennifer C. King, PhD, GO2 Foundation for Lung Cancer

Palliative Care Interventions as Optimal Lung Cancer Care. Jennifer S. Temel, MD, Massachusetts General Hospital

Looking Through the Equity Lens: Vulnerable Populations with Lung Cancer. Narjust Duma, MD, Dana-Farber Cancer Institute3:05pm – 3:15pm ETCLOSING REMARKS and END OF DAY 1

Ella Kazerooni, MD, MS, FACR, FSABI, NLCRT Chair, University of MichiganSession Descriptions & Recordings10:00am – 10:40am ET

Session Video


Welcome and Opening Remarks
Douglas E. Wood, MD, FACS, NLCRT Vice-Chair, University of Washington

Patient Advocate Story (Video)

Heidi N. Onda, The White Ribbon Project
Pierre T. Onda, MD, The White Ribbon Project

NLCRT Remembrance of Pierre P. Massion, MD

Jennifer A. Lewis, MD, MS, MPH, Vanderbilt University Medical Center
Gerard A. Silvestri, MD, MS, FCCP, Medical University of South Carolina11:00am – 12:40 pm ET


Session Video

Building Equitable Lung Cancer Control and Care for All


Keynote Speaker

Robert A. Winn, MD, Massey Cancer Center at Virginia Commonwealth University


Brandi Bryant, Team Draft
Manali I. Patel, MD, MPH, MS, Stanford University
Marshall H. Chin, MD, MPH, FACP, University of Chicago
Nicole Richie, PhD, Genentech


Gerard A. Silvestri, MD, MS, FCCP, Medical University of South Carolina1:05am – 2:30 pm ET


Session Video


Farhood Farjah, MD, MPH, FACSUniversity of Washington

Campaign to End Lung Cancer Stigma – A National Initiative


Overview of Campaign, Summit, and Future. Lisa M. Carter, PhD, APRN, ANP-C, FAAN, Memorial Sloan Kettering Cancer Center

Lung Cancer Stigma and the Veterans Community. James Pantelas, Veterans Health Administration

IASLC Language Guide. Kristin Ito, International Association for the Study of Lung Cancer

Empathic Communications Skills Training. Jamie S. Ostroff, PhD, Memorial Sloan Kettering Cancer Center

Lung Cancer Stigma Health System Assessment Guide. Jamie L. Studts, PhD, University of Colorado

Optimizing Lung Cancer Biomarkers in Practice – A National Initiative


Biomarker Testing Guidelines Consensus Panel. M. Patricia Rivera, MD, ATSF, FCCP, University of North Carolina at Chapel Hill

Biomarker Testing Playbook. Bruce E. Johnson, MD, FASCO, Dana-Farber Cancer Institute

Biomarker Testing Turnaround Time. Ignacio I. Wistuba, MD, MD Anderson Cancer Center

Addressing Comprehensive Lung Cancer Biomarker Testing Through Project ECHO. Raymond U. Osarogiagbon, MBBS, FACP, Baptist Cancer Center2:45pm – 4:05pm ET


Session Video


Joelle T. Fathi, DNP, RN, ARNP, CTTS, FAAN, University of Washington


State-Based Lung Cancer Coalition-Building Guide. Jessica E. Olson, PhD, MPH, Medical College of Wisconsin

LungPLAN: Projecting Lung Assessment Needs. Carey C. Thomson, MD, MPH, ATSF, Mt. Auburn Hospital/Beth Israel Lahey Health

Multimodal Intervention Strategies to Improve Lung Cancer Screening for Women Undergoing Breast Screening. Kim L. Sandler, MD, Vanderbilt University Medical Center

Partnership with American Academy of Family Physicians. Robert J. Volk, PhD, MD Anderson Cancer Center

Lung Cancer Screening Webinar & Podcast Series for the Lung Cancer Community. Efren J. Flores, MD, Massachusetts General Hospital4:05pm – 4:15pm ETCLOSING REMARKS AND END OF ANNUAL MEETING

Ella Kazerooni, MD, MS, FACR, FSABI, NLCRT Chair, University of Michigan
Douglas Wood, MD, FACS, FRCSEd, NLCRT Vice-Chair, University of Washington